Literature DB >> 6261133

Plasma levels of delta 9-tetrahydrocannabinol after intravenous, oral, and smoke administration.

A Ohlsson, J E Lindgren, A Wahlen, S Agurell, L E Hollister, H K Gillespie.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6261133

Source DB:  PubMed          Journal:  NIDA Res Monogr        ISSN: 1046-9516


× No keyword cloud information.
  7 in total

Review 1.  Human cannabinoid pharmacokinetics.

Authors:  Marilyn A Huestis
Journal:  Chem Biodivers       Date:  2007-08       Impact factor: 2.408

Review 2.  The acute effects of cannabinoids on memory in humans: a review.

Authors:  Mohini Ranganathan; Deepak Cyril D'Souza
Journal:  Psychopharmacology (Berl)       Date:  2006-09-26       Impact factor: 4.530

3.  Reinforcing properties of oral delta 9-tetrahydrocannabinol, smoked marijuana, and nabilone: influence of previous marijuana use.

Authors:  J H Mendelson; N K Mello
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

Review 4.  Preclinical studies on the reinforcing effects of cannabinoids. A tribute to the scientific research of Dr. Steve Goldberg.

Authors:  Gianluigi Tanda
Journal:  Psychopharmacology (Berl)       Date:  2016-03-30       Impact factor: 4.530

5.  Single and multiple doses of rimonabant antagonize acute effects of smoked cannabis in male cannabis users.

Authors:  Marilyn A Huestis; Susan J Boyd; Stephen J Heishman; Kenzie L Preston; Denis Bonnet; Gerard Le Fur; David A Gorelick
Journal:  Psychopharmacology (Berl)       Date:  2007-07-10       Impact factor: 4.530

6.  Oral THC produces minimal behavioral alterations in preadolescent rats.

Authors:  Diana Dow-Edwards; Ning Zhao
Journal:  Neurotoxicol Teratol       Date:  2008-03-21       Impact factor: 3.763

7.  Using Population Pharmacokinetic Modeling to Estimate Exposure to Δ9-Tetrahydrocannabinol in an Observational Study of Cannabis Smokers in Colorado.

Authors:  Cristina Sempio; L Cinnamon Bidwell; Kent Hutchison; Marilyn A Huestis; Jost Klawitter; Uwe Christians; Thomas K Henthorn
Journal:  Ther Drug Monit       Date:  2021-08-01       Impact factor: 3.118

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.